General Practice · El Centro, CA
NPI
1427461532
Since 2014
Specialty
General Practice
Code 208D00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
1550 Pepper Dr Ste A
El Centro, CA, 92243
Phone (760) 312-5900
Groups this clinician bills Medicare through
Medicare paid, 2024
$4,439
247 services
Medicare patients, 2024
102
Average age 69
Drug cost, 2024
$5.4M
4,146 prescriptions
Company payments, 2025
$945
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Owais Ahmad was code 82947 (clinical chemistry), 85 times for 49 patients. In total Owais Ahmad billed 247 services in 38 codes, and Medicare paid $4,439.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 82947 Clinical Chemistry | Office | 85 | 49 | $3.85 | $327 |
| 83036 Blood Count | Office | 35 | 31 | $4.36 | $153 |
| 82950 Clinical Chemistry | Office | 20 | 15 | $1.15 | $23 |
| 93005 Electrocardiogram | Office | 15 | 15 | $4.35 | $65.28 |
| 87426 Immunoassay | Office | 13 | 13 | $34.62 | $450 |
| 71046 X-ray - Chest | Office | 12 | 12 | $11.17 | $134 |
By year: 2022 $5,804 for 429 services; 2023 $10K for 803 services; 2024 $4,439 for 247 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 82947 Clinical Chemistry | 85 | 49 | $3.85 | $327 |
| 83036 Blood Count | 35 | 31 | $4.36 | $153 |
| 82950 Clinical Chemistry | 20 | 15 | $1.15 | $23 |
| 87426 Immunoassay | 13 | 13 | $34.62 | $450 |
Medicare prescription drug claims, 2024
In 2024, the drug Owais Ahmad prescribed most often to Medicare patients was Rosuvastatin Calcium, with 292 prescriptions and refills. In total Owais Ahmad wrote 4,146 Medicare prescriptions that cost $5.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 292 | 580 | 81 | $6,168 |
| Ozempic Semaglutide | 241 | 259 | 41 | $234K |
| Atorvastatin Calcium Generic | 237 | 547 | 71 | $3,106 |
| Lisinopril Generic | 231 | 540 | 68 | $1,580 |
| Metformin Hcl Generic | 159 | 338 | 50 | $1,427 |
| Farxiga Dapagliflozin Propanediol | 156 | 188 | 29 | $101K |
| Amlodipine Besylate Generic | 138 | 305 | 39 | $1,031 |
| Losartan Potassium Generic | 135 | 275 | 37 | $1,233 |
| Alendronate Sodium Generic | 126 | 290 | 37 | $1,494 |
| Levothyroxine Sodium Generic | 120 | 272 | 35 | $1,609 |
| Clopidogrel Clopidogrel Bisulfate | 114 | 248 | 35 | $1,776 |
| Korlym Mifepristone | 112 | 112 | 19 | $4.4M |
| Spironolactone Generic | 110 | 154 | 23 | $796 |
| Metoprolol Succinate Generic | 95 | 171 | 26 | $1,386 |
| Montelukast Sodium Generic | 94 | 171 | 30 | $1,260 |
Brand drugs: 1,098 claims; generic drugs: 3,036 claims; opioid claims: 69.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Owais Ahmad $945 ($945 in general payments such as food, travel and fees) from 15 companies. The largest payer was Lilly USA, LLC with $186.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 6 | $186 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $165 |
| Recordati_rare_diseases_inc. | 3 | $80.64 |
| Novo Nordisk Inc NVO | 4 | $80.48 |
| Corcept Therapeutics CORT | 3 | $78.39 |
| GlaxoSmithKline, LLC. GSK | 4 | $75.3 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65.95 |
| Tandem Diabetes Care, Inc. TNDM | 2 | $48.31 |
| CeQur Corporation | 1 | $27.94 |
| Exact Sciences Corporation EXAS | 1 | $27.19 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.